According to the resume, Wu Yiling, 1949, 10 was born in Gucheng County, Hengshui City, Hebei Province on October 24th. In June 2006, Beijing Yiling Pharmaceutical Co., Ltd. was incorporated. At present, he is an expert in cardiovascular diseases of traditional Chinese medicine, an academician of China Academy of Engineering, vice president, professor and doctoral supervisor of Hebei Medical University, and chairman of Yiling Pharmaceutical.
"Wu Xiangjun is the general manager and non-independent director of Yiling Pharmaceutical. According to the resume, Wu Xiangjun was born in 1975, with China nationality and no right of abode abroad. Master of Traditional Chinese Medicine, Master of Business Administration in university of greenwich, UK, Deputy Chief Physician. He and Wu Yiling are father and son. "
Yiling pharmaceutical of Wu family;
According to the company's annual report, Wu Yiling, the founder of Yiling Pharmaceutical, holds 365,438+0.53%, Wu Xiangjun, his son, 20.865,438+0%, Ray Wu, his daughter, 2.34% and Wu Xizhen, his sister, 0.36%. As a concerted action, the Wu family firmly holds the right to speak of Yiling Pharmaceutical, a 10 billion listed company.
According to public information, Wu Yiling, 1949+00 was born in Gucheng County, Hengshui City, Hebei Province in June. The Wu family is a family of traditional Chinese medicine, and Wu's father is famous in the local area. 1977 After resuming the college entrance examination, Wu Yiling was admitted to the Department of Traditional Chinese Medicine of Hebei Medical University. Only one year later, Wu Yiling, a freshman, went directly to Nanjing College of Traditional Chinese Medicine (now Nanjing University of Traditional Chinese Medicine) for postgraduate study. 1982, graduated from Nanjing College of Traditional Chinese Medicine for the first time, and was assigned to work in the Cardiovascular Department of Hebei Provincial Hospital of Traditional Chinese Medicine.
Beijing Youth Daily reporter learned that 1992, Wu Yiling left the hospital and founded a medical research institute in Shijiazhuang High-tech Industrial Development Zone. 1993, Wu Yiling decided to acquire 26 mu of land in the development zone to build its own pharmaceutical factory and hospital. At the beginning of 1995, the pharmaceutical factory was officially put into production, and later Yiling Pharmaceutical came into being.
The performance of Yiling Pharmaceutical is mainly driven by its drugs. According to the data, Yiling Pharmaceutical currently has 13 patented Chinese medicine varieties, of which 8 are listed in the national medical insurance catalogue and 5 are listed in the national essential drugs catalogue.
According to the financial report of Yiling Pharmaceutical, in 20021year, Yiling Pharmaceutical's products performed strongly in the field of cardiovascular and cerebrovascular diseases, that is, Tongxinluo, Shensongyangxin and Qiliqiangxin achieved total sales revenue, accounting for 44.82% of the revenue, up 3 1.56% year-on-year, and once again became the field with the largest proportion of revenue. As one of the company's main products.